A study showed that there were binding sites between Nell-1 and Osterix, and Osterix acted as a negative regulator of Nell-1 in Saos-2, U2OS, HeLa and Glioma cells (Chen et al., 2011). This evidence concerns the gene NELL1 and central nervous system cancer.